|Opening Date||03, November 2022|
|Closing Date||07, November 2022|
|Refund Initiation||14, November 2022|
|Listing Date||16, November 2022|
|Face Value||₹2 per equity share|
|IPO Price Band||₹319 to ₹336 per equity share|
|Minimum Order Quantity||44 Shares|
|Issue Size||₹2,205.57 Cr|
The month of October 2022, saw a couple of IPOs getting listed in the secondary market. These were Electronics Mart India Ltd and Tracxn Technologies Ltd. Whereas Electronics Mart India Ltd proved to be a once in a lifetime opportunity, generating 43% listing gains, Tracxn Technologies also performed superbly, listing at 17% returns. The retail subscription for these IPOs saw an overwhelming response, describing that retail investors are eager to to invest. After Electronics Mart India Ltd, which received a whopping 20.77 times subscription from retail investors, all eyes are now aimed at Global Health, which is going live with its IPO on 03rd November. Let’s learn in detail all its financials and if this Upcoming IPO 2023 is worth investing in or not!
Incorporated in the year 2009, Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.
Under the brand - “Medanta”, the company has a network of 5 hospitals currently operating in Gurugram, Indore, Ranchi, Lucknow and Patna and 1 hospital in Noida, which is under construction. As of June 30, 2022, the company provides healthcare services in over 30 medical specialties and engages over 1,300 doctors.
The financials of the company for the last three years are detailed as below -
|Particulars||As of and for the Financial Year ended March 31|
|Equity share capital||495.86||493.45||491.33|
|Assets (Current & Non-Current)||26,941.05||26,662.87||24,300.05|
|Revenue from Operations||14,467.43||15,004.22||14,558.02|
|Profit/ (Loss) after Tax||288.05||363.27||513.03|
|Return on Net Worth||2.08%||2.69%||3.96%|
|Earnings per share (₹/share, diluted)||1.14||1.44||2.04|
all numbers stated are in million.
Let’s now move onto the main part of this article. Here, we’re going to be looking at some of the most important details of this upcoming IPO viz - Global Health date and its share price.
According to the Red Herring Prospectus filed by the company, the public issue of the equity shares is going live from November 03 and will be available for subscription until November 07, 2022.
The total issue size of the latest Global Health is declared to be ₹2,205.57 crores. This is a mix of a fresh issue, and an offer for sale. The company is offloading 48,440,000 equity shares in OFS and is raising ₹500 crores via fresh issue.
50% of the offer is for QIBs (Qualified Institutional Buyers), 35% for retail investors, and the balance 15% for NIBs (Non-institutional Investors).
The price band of the company’s upcoming IPO is declared to range between ₹319 to ₹336 per equity share
Since the IPO of Global Health is from the mainboard, it would be listed on both - the National Stock Exchange (NSE) as well as the Bombay Stock Exchange (BSE)
The net proceeds of the Issue, i.e. gross proceeds of the Issue (“from Fresh Issue”) are proposed to be utilized in the following manner:
If you wish to become a part of this exciting IPO opportunity, you will need to have an online demat and trading account, which will help you get shares of your favorite companies. To get an online DEMAT account for Free*, all you have to do is sign-up with Motilal Oswal and get started.
If you are an existing customer with Motilal Oswal, you can now invest in the IPOs in just one click through UPI payment!
It’s all easy. It’s all good.